SCHEMBL30295769

SCHEMBL30295769

CCCN(C)c1ncnc2c1c(-c1cccc(Cl)c1)cn2COCC[Si](C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ STK4 Q13043 5/20 0.53
▸ STK3 Q13188 5/20 0.53
▸ LRRK2 Q5S007 2/20 0.44
▸ TP53 P04637 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ SRC P12931 3/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ ABL2 P42684 1/20 0.37
▸ ADK P55263 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.35
▸ RIPK2 O43353 1/20 0.34
▸ SLC6A9 P48067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30295914 0.92 STK4 (0.54) STK4STK3LRRK2TP53LMNA
SCHEMBL30295798 0.86 STK4 (0.56) STK4STK3LRRK2TP53LMNA
SCHEMBL30295768 0.86 STK4 (0.45) STK4STK3LRRK2TP53LMNA
SCHEMBL30295858 0.85 STK4 (0.55) STK4STK3LRRK2TP53LMNA
SCHEMBL30295700 0.84 SRC (0.42) STK4STK3LRRK2TP53LMNA
SCHEMBL31301813 0.83 STK4 (0.44) STK4STK3LRRK2TP53LMNA
SCHEMBL30295881 0.80 STK4 (0.44) STK4STK3LRRK2TP53LMNA
SCHEMBL30295820 0.80 LMNA (0.49) STK4STK3LRRK2TP53LMNA
SCHEMBL30295902 0.78 STK4 (0.44) STK4STK3LRRK2TP53LMNA
SCHEMBL30295809 0.78 LMNA (0.46) STK4STK3LRRK2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055731-A1 INHIBITORS OF SERINE/THREONINE PROTEIN KINASE STK3 OR STK4 AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2023-04-06 — — WO disclosed
Send feedback